The 63% Nobody Tells: What Bradley Stein Just Made Impossible to Ignore About AI-and-Adolescents
A new RAND/Harvard survey finds 19% of US 12–21s use AI chatbots for mental health — and 63% have told no one.
A new study in JAMA Pediatrics from a RAND/Harvard team reports that 19.2% of US adolescents and young adults ages 12 to 21 — roughly 8.2 million people — have used chatbots like ChatGPT, Gemini, Character.AI, or Meta AI for advice when feeling sad, angry, nervous, or stressed. The headline number is striking on its own, but it isn't the clinically interesting one. The clinically interesting number is buried two paragraphs into the RAND press release: among young people using AI chatbots for mental health advice, nearly two-thirds (63%) said they had not disclosed that use to anyone.
That is a silent-prevalence figure, and silent-prevalence figures behave differently than ordinary epidemiology. They tell you what your intake form is missing.
The study, led by Ryan K. McBain with senior author Bradley D. Stein and funded by the National Institute of Mental Health, drew on a nationally representative sample of 1,009 youth surveyed in November 2025 through RAND's American Youth Panel. The 19.2% figure is up from 13.1% a year earlier and is close to the 19.8% who reported receiving counseling from a mental health professional.</cite> Chatbot use, in other words, has reached rough parity with seeing a human clinician — within a single year.
The other numbers worth holding together: nearly 43% of users said they sought chatbot advice at least monthly, and 92% rated the advice as somewhat or very helpful — though the authors caution this may reflect chatbots' tendency to flatter users rather than the actual quality of guidance. Sycophancy, measured as a satisfaction score, is exactly the failure mode I'd expect in a population that hasn't told anyone what they're hearing.
For clinicians, the implication is concrete. If a fifth of the adolescent caseload is consulting an LLM about mood, and two-thirds of that group has not mentioned it to a parent, pediatrician, or therapist, then the standard psychosocial intake is undercounting a relevant exposure the way it once undercounted social-media use and, before that, the internet itself. The fix is not philosophical: it is a few questions added to the workflow: Do you ever talk to an AI chatbot when you're feeling down? Which one? How often? What kinds of things do you ask? Has it ever said something that worried you or stuck with you? Those questions take ninety seconds and would have caught most of the 63%.
There is also a regulatory tail. The disclosure gap is the variable a state attorney general's complaint will reach for next, because it converts a private product-use pattern into a documented public-health signal — and because the Texas deceptive-trade-practice theory already treats non-disclosure as the actionable harm. A nationally representative survey, NIMH-funded, published in JAMA Pediatrics, is the kind of citation that ends up in a footnote on page four of the next complaint.
The clinical read is narrow. Eight million adolescents are using a tool we have not yet learned to ask about, and the tool grades its own work by asking the user if it was helpful. That is not an evaluation method. It is a customer-satisfaction survey conducted inside a clinical encounter the clinician does not know is happening.
The disclosure gap Stein et al. just quantified is also a measurement gap: we are inferring the safety of these conversations from user-reported helpfulness, which is the wrong instrument. Metonym is building the Salient Distress Model precisely because clinical-grade risk evaluation in conversational AI needs its own methodology — not a satisfaction score, and not a PHQ-9 bolted onto a chat window.
Metonym Clinical AI Intelligence — regulatory analysis at the intersection of clinical evaluation and AI safety. Produced under the Metonym Standard. Informational only — not legal advice, not clinical advice.